Monitoring Gesetzessammlung

Gesetze und Verordnungen USA alphabetisch

A B C D E F G H I J
K L M N O P Q R S T
U V W X Y Z
0 1 2 3 4 5 6 7 8 9
§ 353a - Pharmacy compounding
21 USC 353a
§ 353a–1 - Enhanced communication
21 USC 353a–1
§ 353b - Outsourcing facilities
21 USC 353b
§ 353c - Prereview of television advertisements
21 USC 353c
§ 353d - Process to update labeling for certain generic drugs
21 USC 353d
§ 354 - Veterinary feed directive drugs
21 USC 354
§ 355 - New drugs
21 USC 355
§ 355–1 - Risk evaluation and mitigation strategies
21 USC 355–1
§ 355–2 - Actions for delays of generic drugs and biosimilar biological products
21 USC 355–2
§ 355a - Pediatric studies of drugs
21 USC 355a
§ 355b - Adverse-event reporting
21 USC 355b
§ 355c - Research into pediatric uses for drugs and biological products
21 USC 355c
§ 355c–1 - Report
21 USC 355c–1
§ 355d - Internal committee for review of pediatric plans, assessments, deferrals, deferral extensions, and waivers
21 USC 355d
§ 355e - Pharmaceutical security
21 USC 355e
§ 355f - Extension of exclusivity period for new qualified infectious disease products
21 USC 355f
§ 355g - Utilizing real world evidence
21 USC 355g
§ 355h - Regulation of certain nonprescription drugs that are marketed without an approved drug application
21 USC 355h
§ 356 - Expedited approval of drugs for serious or life-threatening diseases or conditions
21 USC 356
§ 356–1 - Accelerated approval of priority countermeasures
21 USC 356–1
Verwendung von Cookies.

Durch die Nutzung dieser Website akzeptieren Sie automatisch, dass wir Cookies verwenden. Cookie-Richtlinie

Akzeptieren
Markierungen
Leseansicht